CD11c+CD88+CD317+ myeloid cells are critical mediators of persistent CNS autoimmunity
N. Manouchehri, R. Hussain, P. Cravens, B. Edelson, G. Wu, A. Cross, R. Doelger, N. Loof, T. Eagar, T. Forsthuber, L. Calvier, J. Herz, O. Stuve
This study identifies CD11c+CD88+CD317+ myeloid cells as key drivers of CNS autoimmunity and shows that targeting these cells with anti-CD317 mAb reduces disease.
bioRxiv · Jun 10, 2020Immunology